Peer Review History
| Original SubmissionJuly 15, 2023 |
|---|
|
PONE-D-23-21143Perinatal outcome of twin pregnancy and mode of birth in marginalized migrant and refugee populations on the Thai Myanmar border: a population cohort.PLOS ONE Dear Dr. Prins, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== Please respond to all reviewers comments point by point ============================== Please submit your revised manuscript by Dec 08 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Ahmed Mohamed Maged, MD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Note from Emily Chenette, Editor in Chief of PLOS ONE, and Iain Hrynaszkiewicz, Director of Open Research Solutions at PLOS: Did you know that depositing data in a repository is associated with up to a 25% citation advantage (https://doi.org/10.1371/journal.pone.0230416)? If you’ve not already done so, consider depositing your raw data in a repository to ensure your work is read, appreciated and cited by the largest possible audience. You’ll also earn an Accessible Data icon on your published paper if you deposit your data in any participating repository (https://plos.org/open-science/open-data/#accessible-data). 3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 4. Thank you for stating in your Funding Statement: "JAS is supported by an Australian National Health and Medical Research Council Leadership Investigator Grant (#1196068). This project is partially supported by Chiang Mai University to TJP and CA. The others authors received no funding for this study. The Shoklo Malaria Research Unit is supported in part by the Wellcome-Trust Major Overseas Programme in Southeast Asia (grant number 220211, https://doi.org/10.35802/220211; lead applicant Nicholas Day). For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission." Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now. Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf. 5. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 6. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: GENERAL OVERVIEW, ORIGINALITY This paper retrospectively addresses the outcome of twin versus singleton deliveries in low- and middle-income countries with still some barriers to accessing hospital care, specifically in refugee and migrant clinics on the Thai Myanmar border between 1986 and 2020. Even though we know that twin pregnancies and deliveries carry higher risks for maternal and neonatal morbidity and mortality, the paper implies interesting aspects since the care is still concentrated on a few essentials without the chance of careful prevention of problems. APPROACH /RESULTS TITLE: The title might also imply the comparison, the authors performed, e.g.: “Comparison of perinatal outcome and mode of birth between twin and singleton pregnancies in migrant and refugee populations on the Thai Myanmar border: a population cohort”. ABSTRACT: Clear INTROCUCTION: Please use the term “Caesarean delivery” instead of “section” throughout the paper; alternatively, they might say only cesareans. METHODS. It is a pity, that the authors excluded deliveries > 28weeks although it has been shown that in vertex-first twins between 26 and 32 weeks a vaginal delivery is possible in 213/248 cases (86%) and a planned vaginal delivery had no negative impact on the outcome as compared to a primary Cesarean (Sentilhes L et al. Neonatal outcome of very preterm twins: policy of planned vaginal or cesarean delivery. AJOG 2015;213(1):73 e1- e7.6). Similarly, in the JUMODA-Study with 232 cases with planned vaginal delivery and 192 planned cesareans there were no significant differences in survival without detected morbidity: 80.8% versus 80.2% (Korb et al. Survival without severe neonatal morbidity in very preterm twins according to planned mode of delivery. AJOG 2021;Suppl.1 , A.16, p.9). The authors should better explain why they excluded all deliveries < 28 gestational weeks, although this is an important outcome per se. It was for me not completely clear whether the stillbirth rate was determined in the whole population or only in those with an expected gestational age of > 28 gestational weeks, please express this explicitly. It remains completely unclear whether the attending obstetricians had sufficient training to perform vaginal deliveries in twins. Was there any attempt to differentiate between MC and DC twin pregnancy? Please specify who finally attended the twin deliveries and whether there protocols, e.g. for how long did they wait when the second twin was in breech or transverse presentation? Were they trained to perform internal version and/or breech extraction in the second twin, e.g. Arabin B, Kyvernitakis I. Vaginal delivery of the second nonvertex twin: avoiding a poor outcome when the presenting part is not engaged. Obstet Gynecol. 2011;118(4):950-4? Although the authors report on ethical approval, this might not even have been required in accordance with the guidelines of the working group for the survey and utilization of secondary data (AGENS). Last but not least: Were the data stored only as paper charts or also electronically? Unfortunately, this is not clearly stated. RESULTS In Figure 1, the authors demonstrate the “Flow Chart” of data and patients lost to follow up. Can the authors explain the high rate of > 15 000 pregnancies with lost to follow up or unknown outcome among singleton pregnancies? Can they explain that in both cohorts around 40% of Apgar values were missing? Table 1 compares characteristics of twin and singleton cohorts, Table 3 the mode of delivery of twin 1, 2 and singletons. The authors should also demonstrate significant differences between the cohorts in a further column. The authors should also explain whether life born neonates had access to a neonatal intensive care unit (NICU). In addition, it would be interesting to know the suspected reasons for maternal death in both cohorts given the serious consequences for the families and societies. The authors should also try to evaluate and whether there was an improvement over time in both cohorts. ADEQUACY DISCUSSION PRINCIPAL FINDINGS: When the authors briefly summarize the results, they already admit that there was no improvement of perinatal mortality over time within the twin cohort. This is a serious outcome because even in this population the outcome of singletons improved. There might be several reasons, which should be debated and proposed to local health care politicians such as a) early ultrasound for all pregnant women to diagnose not only a multiple pregnancy but also chorionicity. The authors should debate that given the low overall twin rate of this cohort the relative contribution of MCDA or even MCMA twins might be high, e.g. up to nearly 50% as compared to Western populations of where it is only one third. The fact that stillbirths at the end of pregnancy mainly occur in these MC twin pregnancies is well known, but the conclusions not to induce labor at about 36-37 weeks might be wrong if diagnosis by ultrasound and FHR monitoring is available. Another serious aspect seems to be the lack of teaching how to perform vaginal deliveries of twins, which can be taught. The poor skills are mainly reflected in the relative increase of cesareans in the second twin (combined twin deliveries), which is frequently iatrogenic reflecting poor skills of the physicians in charge. Combined deliveries also carry the highest risks of poor maternal and neonatal outcome. Rapid manual delivery of the second twin is mandatory in all cases where the second twin is not in vertex position and it would be interesting to know the time interval between the delivery of the first and second twin. Teaching –possibly with mannequins- and measuring the time interval is even possible in poor settings and seems mandatory. MEANING OF THE FINDINGS/ CLINICAL IMPLICATIONS The authors should also define the weight difference between the twins, e.g. discordance in cases where both birth weights are available. From the published data, weak evidence may support consideration of cesarean delivery in extremes of discordance, from a practical standpoint, this may apply when the second twin is approximately >40% larger than the presenting co-twin (Christopher D et al: An Evidence-Based Approach to Determining Route of Delivery for Twin Gestations. Rev Obstet Gynecol. 2011;4(3/4):109-116) but also when it is largely smaller (more frequent). RESEARCH IMPLICATIONS: Prospective designs if available with consequent teaching efforts in early ultrasound and practical skills in vaginal delivery including pain treatment for manual maneuvers. STRENGTH AND WEAKNESSES: Strengths: As the authors, describe. It is interesting to see these results in settings without ART but also without any defensive medicine, where basic needs are the main issue. Weaknesses: The impact for improvement politics by better access to prenatal care, ultrasound and skilled operators during birth is hard to evaluate in a retrospective setting but mandatory for the future. CONCLUSIONS The intention of this paper is to praise to mirror the outcome of both, singleton and twin pregnancies in a region with low income and a high rate of refugees. Therefore, it should be published. Several weaknesses are discussed and these aspects should be considered in a professional way. The conclusion of the paper should be very clear and strong to improve the care for both, the outcomes of mothers and their offspring in singleton and even more in twin pregnancies. Reviewer #2: I am not sure that I misunderstand for the number of cases in table 3, please check the number of twin pregnancy (n=595) but in the detail: birthed vaginally is 597. Line 231, 2946 grams should be 2,946 grams. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Comparison of perinatal outcome and mode of birth of twin and singleton pregnancies in migrant and refugee populations on the Thai Myanmar border: a population cohort. PONE-D-23-21143R1 Dear Dr. Prins, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at http://www.editorialmanager.com/pone/ and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Ahmed Mohamed Maged, MD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have now considered the aspects previously criticized and improved the manuscript. To conclude, the manuscript should now be considered for publication. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No ********** |
| Formally Accepted |
|
PONE-D-23-21143R1 PLOS ONE Dear Dr. Prins, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Professor Ahmed Mohamed Maged Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .